Incyte Stock Analysis

Incyte Stock Analysis Notes

About 98.0% of the company shares are owned by institutional investors. The book value of Incyte was currently reported as 16.45. The company has Price/Earnings To Growth (PEG) ratio of 0.61. Incyte had not issued any dividends in recent years. The entity had 2:1 split on the 1st of September 2000. Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware. Incyte Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 2094 people. To learn more about Incyte call Herve Hoppenot at 302 498 6700 or check out https://www.incyte.com.

Incyte Investment Alerts

Incyte Upcoming and Recent Events

Incyte Largest EPS Surprises

View All Earnings Estimates

Incyte Environmental, Social, and Governance (ESG) Scores

Incyte Stock Institutional Investors

Note, although Incyte's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Incyte Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 13.82 B.

Incyte Profitablity

The company has Profit Margin (PM) of 0.01 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.15 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.15.

Management Efficiency

Return On Tangible Assets is likely to rise to 0.1 in 2024. Return On Capital Employed is likely to rise to 0.12 in 2024. At this time, Incyte's Return On Assets are fairly stable compared to the past year. Incyte's management efficiency ratios could be used to measure how well Incyte manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 25th of November, Incyte retains the Risk Adjusted Performance of 0.0774, market risk adjusted performance of 0.2132, and Downside Deviation of 2.28. Incyte technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Incyte Price Movement Analysis

Incyte Insider Trading Activities

Incyte Outstanding Bonds

Incyte Predictive Daily Indicators

Incyte Corporate Filings

Incyte Forecast Models

Incyte's time-series forecasting models are one of many Incyte's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Incyte's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Incyte prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Incyte shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Incyte. By using and applying Incyte Stock analysis, traders can create a robust methodology for identifying Incyte entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Incyte analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Incyte analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Incyte stock analysis indicators help investors evaluate how Incyte stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Incyte shares will generate the highest return on investment. By understating and applying Incyte stock analysis, traders can identify Incyte position entry and exit signals to maximize returns.

When running Incyte's price analysis, check to measure Incyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte is operating at the current time. Most of Incyte's value examination focuses on studying past and present price action to predict the probability of Incyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Incyte's price. Additionally, you may evaluate how the addition of Incyte to your portfolios can decrease your overall portfolio volatility.